raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:102724

Acute myeloid leukemia with t(8;21)(q22;q22) translocation

Synonyms: AML with t(8;21)(q22;q22) translocation

Type
Disease
Group
Disorder
Age of onset
Adolescent, Adult, Childhood
Status
active

A rare acute myeloid leukemia with recurrent genetic anomaly disorder characterized by a t(8;21)(q22;q22) balanced translocation cytogenetic abnormality, forming a RUNX1-RUNX1T1 fusion gene, presenting with morphological characteristics which include myeloblasts with indented nuclei, basophilic cytoplasm with a prominent paranuclear hof that may contain a few azurophilic granules, prominent and possibly large promyelocytes, myelocytes and metamyelocytes, easily identifiable Auer rods and, more variably, bone marrow eosinophilia. Myeloid sarcoma is frequently present at diagnosis. Detection of the t(8;21)(q22;22) translocation is sufficient for diagnosis irrespective of blast count.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcute myeloid leukemia with t(8;21)(q22;q22) translocationAML with t(8;21)(q22;q22) translocation
frLeucémie myéloblastique aiguë type associée à une translocation t(8;21)(q22;q22)
deAkute myeloische Leukämie mit Translokation t(8;21)(q22;q22)AML mit Translokation t(8;21)(q22;q22)
esLeucemia mieloide aguda con traslocación t(8;21)(q22;q22)LMA con translocación t(8;21)(q22;q22)
itLeucemia mieloide acuta con traslocazione t(8;21)(q22;q22)AML con traslocazione t(8;21)(q22;q22)
nlAcute myeloïde leukemie met t(8;21)(q22;q22) translocatieAML met t(8;21)(q22;q22) translocatie
ptLeucemia mielóide aguda com translocação t(8;21)(q22;q22)
plOstra białaczka szpikowa z translokacją t(8;21)(q22;q22)AML z translokacją t(8;21)(q22;q22)
csAkutní myeloidní leukémie s t(8;21)(q22;q22) translokacíAML s t(8;21)(q22;q22) translokací
ukГостра мієлоїдна лейкемія з транслокацією t(8;21)(q22;q22)ГМЛ з транслокацією t(8;21)(q22;q22)
zh急性髓系白血病伴t(8;21)(q22;q22)易位急性髓性白血病伴t(8;21)(q22;q22)
trt (8; 21) (q22; q22) translokasyonlu akut miyeloid lösemit(8; 21) (q22; q22) translokasyonu ile seyreden AML

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C92.0NTBTinclusionvalidated
ICD-112A60.0NTBTindexvalidated
MONDO0015166Evalidated
UMLSC1292774Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

5 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CEBPABiomarker tested inAssessedHGNC:1833ENSG0000024584811689719q13.11CCAAT enhancer binding protein alpha
FLT3Biomarker tested inAssessedHGNC:3765ENSG0000012202513635113q12.2fms related receptor tyrosine kinase 323783394[PMID]
KITBiomarker tested inAssessedHGNC:6342ENSG000001574041649204q12KIT proto-oncogene, receptor tyrosine kinase23783394[PMID]_24226631[PMID]
RUNX1Part of a fusion gene inAssessedHGNC:10471ENSG0000015921615138521q22.12RUNX family transcription factor 119357394[PMID]
RUNX1T1Part of a fusion gene inAssessedHGNC:1535ENSG000000791021334358q21.3RUNX1 partner transcriptional co-repressor 119357394[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence<1 / 1 000 000—EuropeClass onlyValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card